Perceptronix - Detecting Cancer at its Earliest Stages
Perceptronix - Early Diagnosis, Better Outcomes
           
   

PMI Labs Signs LungSign™ Agreement with Hong Kong Sanatorium & Hospital for Lung Cancer Screening Program

VANCOUVER, CANADA (July 27, 2009) – Perceptronix Medical Inc. Laboratories (PMI Labs) and Hong Kong Sanatorium & Hospital (HKSH), one of the largest private hospitals in Hong Kong, announce the signing of an agreement focused on implementing PMI Labs’ proprietary quantitative cytology approach of analyzing sputum specimens to complement the lung cancer screening program offered by HKSH.

"I am pleased to announce this new partnership between PMI Labs and Hong Kong Sanatorium & Hospital which aims to explore the commercialization of comprehensive analysis of sputum specimens using LungSign™ and quantitative cytology.  We've already identified our first pilot project in which we will provide service from PMI Labs in Vancouver with an ultimate goal of placing scanning instruments and analysis at HKSH in the near future,” says Dr. Bojana Turic, President and CEO of PMI Labs, “This initiative is well in line with our efforts to offer laboratory services not only across Canada but also internationally. We are very happy to be a part of the lung cancer screening program in this reputable hospital.” 

Dr. Lam Bing of HKSH comments, "We're excited to add this technology to the menu of tests we offer to patients in our lung cancer screening program that is pursuing our goal to fight lung cancer disease. We hope this is the first step of our collaboration that will ultimately help patients in need. We are also looking forward to working more with PMI Labs in the future."

During the pilot period of this partnership, high risk patients, mainly smokers, will be identified at HKSH, where sputum specimens will be collected and prepared. Slides will be sent to PMI Labs in Vancouver for further preparation, scanning and analysis. The comprehensive lung cancer program at HKSH uses the latest diagnostic fluorescence and CT equipment. Additional details regarding the agreement were not disclosed.

About LungSign™
LungSign™ offers a safe, virtually painless and convenient method of assessing a patient’s risk of lung cancer. It is based on an automated quantitative cytology analysis of sputum. LungSign™ also serves as a highly relevant and useful complement to current radiological diagnostic methods (e.g. CT).

About PMI Labs
Perceptronix Medical Inc. Laboratories (Vancouver, Canada) provide anatomic pathology and cancer diagnostics services to medical and dental practices in support of earlier diagnoses for better patient outcomes. PMI Labs offers anatomic pathology services with specialized expertise in oncologic pathology, cytopathology, oral pathology, and pathology consultation.
The company uniquely specializes in early cancer detection using quantitative cytology, including tests for oral cancer (OralAdvance™) and lung cancer (LungSign™). Quantitative cytology provides physicians with a distinctive cytopathology assessment based on an objective, computer-based measurement of large-scale DNA abnormality that can indicate precancerous or cancerous changes.

About Hong Kong Sanatorium & Hospital Limited
Hong Kong Sanatorium & Hospital is one of the leading private hospitals in Hong Kong. It is owned by the Li Shu Fan Medical Foundation (LSFMF), a not-for-profit organization. HKSH is committed to fulfilling LSFMF’s vision of providing quality care and advancing medical education and research, with an overriding concern for the public good.

For further information contact:

Dr. Bojana Turic, MD
President & CEO
PMI Labs
Suite 400 - 555 West 8th Avenue
Vancouver, BC, V5Z 1C6
Phone:  604-629-8785 x.228
Email:  bturic@perceptronix.com


Sharon Lun
Corporate Communication Manager
Hong Kong Sanatorium Hospital
Phone : + 2335-7855
Email: sharonlun@hksh.com


 

 

News and Events